Disaggregation of In Vitro Preformed Platelet-Rich Clots by Abciximab Increases Fibrin Exposure and Promotes Fibrinolysis [PDF]
, 2001 J.P. Collet +6 more
openalex +1 more source
Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non-ST-Elevation Acute Coronary Syndromes [PDF]
, 1999 BACKGROUND: Glycoprotein (GP) IIb/IIIa receptor blockers prevent life-threatening cardiac complications in patients with acute coronary syndromes without ST-segment elevation and protect against thrombotic complications associated ...
Akkerhuis, K.M. (Martijn) +5 more
core
Intra-arterial thrombin injection of an ascending aortic pseudoaneurysm complicated by transient ischemic attack and rescued with systemic abciximab [PDF]
, 2001 Peter H. Lin +5 more
openalex +1 more source
Results of percutaneous coronary interventions in Iceland during 1987-1998 [PDF]
, 2008 Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/OpenPurpose: To evaluate potential changes in clinical indications and the composition of the patient population undergoing percutaneous coronary intervention ...
Axel F. Sigurðsson +3 more
core
PLATELET ANTIAGGREGANTS: MECHANISMS OF ACTION AND USE ASOCIED RISKS
Vitae, 2009 Cardiovascular diseases are the main cause of death in the world. Next to efforts to reduce the cardiovascular risk factors, several drugs are resorted to decrease morbimortality associated to these diseases: antihypertensive, antidiabetic, hypolipemiant
Iván F. PALOMO G +4 more
doaj
Differential inhibition of adenosine diphosphate– versus thrombin receptor–activating peptide–stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics [PDF]
, 2001 Artur‐Aron Weber, Karsten Schrör
openalex +1 more source
Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function [PDF]
, 2001 Eli I. Lev +9 more
openalex +1 more source